Ultimo aggiornamento :
19/11/2024
Antalgico   Alfentanil hydrochloride  
Iniezione
Stabilità in soluzione Stabilità in miscela Fattori che influenzano la stabilità Compatibilità metodo di iniezione Bibliografia pdf
   Struttura chimica  

Nome commerciale   Nome commerciale     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alfenta Iran, Perù, Stati Uniti d’America
Alfentanil Canada, Chile, Colombia, Germania, Gran Bretagna, Iran, Stati Uniti d’America
Alfiject Iran
Limifen Spagna
Rapifen Arabia Saudita, Australia, Austria, Belgio, Chile, Danimarca, Finlandia, Francia, Germania, Gran Bretagna, Grecia, Irlanda, Lussemburgo, Malaysia, Norvegia, nuova Zelanda, Paesi Bassi, Polonia, Portogallo, Svezia, Svizzera, Tunisia, Ungheria
Bibliografia   Iniezione   Bibliografia : Alfentanil hydrochloride  
tipo pubblicazione
59 Rivista Trissel LA, Gilbert DL, Martinez JF, Kim MC.
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
299 Rivista Trissel LA, Martinez JF, Gilbert DL.
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
300 Rivista Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
319 Rivista Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999.
660 Rivista Michaels MR, Stauffer GL, Haas DP.
Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility.
Ann Pharmacotherapy 1996 ; 30: 228-232.
815 Rivista Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL.
Stability of ondansetron hydrochloride and 12 medications in plastic syringes.
Am J Health-Syst Pharm 1998 ; 55: 2630-2634.
921 Rivista Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1625 Rivista Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1712 Rivista Trissel LA, Saenz CA.
Compatibility screening of Precedex during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 230-233.
1713 Rivista Trissel LA, Saenz CA.
Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 311-315.
1721 Rivista Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72.
1803 Rivista Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB.
Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2003 ; 60: 80-85.
1861 Rivista Levadoux E, Sautou V, Bazin JE, Schoeffler P, Chopineau J.
Medical plastics: compatibility of alfentanil and propofol alone or mixed. Stability of the alfentanil-propofol mixture.
Int J Pharm 1996 ; 127: 255-259.
1925 Rivista Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
2086 Rivista Sharley NA, Burgess NG.
Stability and compatibility of alfentanil hydrochloride and morphine sulfate in poypropylene syringes.
J Pharm Pract and Res 2003 ; 33: 279-281.
3380 Rivista Eckle V-S, Heim E, Hahn M, Grasshoff C.
Incompatibility of Piritramide with Cephalosporins.
Ann Pharmacotherapy 2013 ;47:426-427.
3502 Laboratorio Propofol (Diprivan®) - Summary of Products Characteristics
Astra Zeneca 2012
3504 Laboratorio Parecoxib (Dynastat®) - Summary of Product Characteristics
Pfizer 2012
3601 Laboratorio Cisatracurium Actavis - Résumé des Caractéristiques du Produit
Actavis 2012

  Mentions Légales